Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.50
Bid: 80.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 5.00 (6.25%)
Open: 82.50
High: 82.50
Low: 82.50
Prev. Close: 82.50
FDBK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Papworth NHS Hosp - contract renewal with Bleepa

21 May 2020 07:00

RNS Number : 5474N
Feedback PLC
21 May 2020
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR").

 

Feedback plc

 

Royal Papworth Hospital NHS Foundation Trust renews contract with Feedback and adopts Bleepa®

 

Contract renewal incorporates use of Bleepa®, the medical grade imaging-based communications platform

Second NHS Trust to adopt Bleepa®

 

London, 21 May 2020: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, today announces Royal Papworth Hospital NHS Foundation Trust ("Trust") has renewed its contract for clinical PACS (picture archiving and communication system) services with Feedback Medical Ltd, a wholly owned subsidiary of the Company. The renewal will incorporate an upgrade to service, providing the Trust access to Bleepa®, Feedback's flagship imaging-based communication platform.

 

The contract, set for a term of 14 months, relates to Feedback's Cadran PACS which has provided core medical imaging services to the Trust since 2001. The contract includes the use of Bleepa® as an upgrade to Cadran Web Viewer and will see Bleepa® made available to all clinicians at the Trust.

 

Royal Papworth Hospital is the UK's leading heart and lung hospital, treating more than 100,000 patients each year. Since carrying out the UK's first successful heart transplant in 1979, the hospital now performs more heart, heart-lung and lung transplants each year than any other UK centre. In addition to transplantation, Royal Papworth Hospital has the UK's largest Respiratory Support and is one of five UK centres providing Extra Corporeal Membrane Oxygenation (ECMO) to patients experiencing severe respiratory failure.

 

For Feedback, the contract marks the second NHS site to adopt Bleepa® as a core imaging tool and is further recognition of the potential that Bleepa® has to enhance clinical care delivery. The first site was the Pennine Acute NHS Hospitals Trust which is using Bleepa® to support frontline staff to manage Covid-19 patients.

 

Tom Oakley, CEO of Feedback plc, said:

"Papworth has been a longstanding customer of Feedback and we are delighted that they recognise the value of Bleepa® as part of this renewal. Enabling critical review at the push of a button, Bleepa® has the functionality to bring significant efficiencies and deliver real time-saving potential for its clinicians. The launch of Bleepa at Papworth is further evidence of the changing needs of frontline clinicians around their interaction with medical imaging and with colleagues, something that we are uniquely positioned to enable. We will now look to continue the spread of Bleepa to other opportunities across the healthcare setting."

 

Bleepa® provides instant and remote access to clinical grade medical images through a zero footprint application. The majority of patient cases require medical imaging which can be seamlessly shared to the entire clinical team through Bleepa®. Cases can be discussed through its secure instant messaging and image annotation, allowing comments and treatment decisions to be communicated instantly between team members. Bleepa® can be accessed from any internet connected device including phones, tablets, laptops and desktops; clinicians can use their own devices and therefore no additional hardware is required.

 

-Ends-

 

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

+44 (0)1954 718072

IR@fbk.com

Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

+44 (0)20 3328 5656

Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey

+44 (0)20 7469 0936

Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

+44 20 3815 8880

Instinctif Partners

Melanie Toyne-Sewell / Phillip Marriage

+44 (0)20 7457 2020

+44 7890 022 814

feedbackplc@instinctif.com

 

 

Notes to editors

 

About Feedback plc - www.fbk.com

 

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.

 

Feedback has launched Bleepa®, a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS). For more information on Bleepa, see www.bleepa.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTURRWRRWUVUAR
Date   Source Headline
3rd May 20117:00 amRNSChange of Adviser
25th Feb 20114:04 pmRNSDirector/PDMR Shareholding
22nd Feb 20118:00 amRNSHalf Yearly Report
18th Feb 20114:16 pmRNSDirectorate Change
11th Feb 201111:58 amRNSDirectorate Change
29th Nov 201010:08 amRNSDirector/PDMR Shareholding
29th Oct 20107:00 amRNSFinal Results
29th Apr 20107:00 amRNSDirector/PDMR Shareholding
28th Apr 20107:00 amRNSDirector/PDMR Shareholding
24th Feb 20107:00 amRNSInterim Results
30th Oct 200911:30 amRNSFinal Results
12th Aug 20097:00 amRNSDirectorate Change
17th Feb 20097:00 amRNSHalf Yearly Report
8th Dec 20084:42 pmRNSDirectorate Change
19th Nov 20087:00 amRNSDirector/PDMR Shareholding
23rd Oct 20087:00 amRNSDirector/PDMR Shareholding
15th Oct 20084:59 pmRNSDirector/PDMR Shareholding
9th Oct 20087:00 amRNSFinal Results
2nd Jun 200812:37 pmRNSHolding(s) in Company
30th May 20085:38 pmRNSTotal Voting Rights
21st May 200811:45 amRNSResult of EGM
24th Apr 20087:55 amRNSProperty Purchase
4th Apr 20087:01 amRNSDirectorate Change
26th Mar 200810:06 amRNSDirectorate Change
28th Feb 20088:06 amRNSInterim Results
11th Feb 20089:21 amRNSUpdate on CVA
10th Jan 20087:00 amRNSDirectorate Change
10th Dec 20075:23 pmRNSCapital Reorganisation
10th Dec 20074:00 pmRNSCapital Reorganisation
13th Nov 20077:00 amRNSDirectorate Change
26th Oct 20073:45 pmRNSDirector/PDMR Shareholding
25th Oct 20071:13 pmRNSOffer Talks Terminated
17th Oct 20071:39 pmRNSStatement re Possible Offer
27th Sep 20077:01 amRNSFinal Results
16th Aug 20079:02 amRNSAIM Rule 26 Information
31st Jul 20073:45 pmRNSTotal Voting Rights
25th Jul 20078:26 amRNSDirectorate Change
20th Jul 20074:41 pmRNSDirector/PDMR Shareholding
18th Jul 20074:07 pmRNSHolding(s) in Company
17th Jul 20071:06 pmRNSHolding(s) in Company
9th Jul 20074:30 pmRNSHolding(s) in Company
5th Jul 200710:16 amRNSHolding(s) in Company
2nd Jul 20071:07 pmRNSResult of EGM
5th Jun 20077:02 amRNSIssue of Equity
2nd May 200711:03 amRNSHolding(s) in Company
30th Apr 200712:28 pmRNSTotal Voting Rights
30th Mar 200710:16 amRNSTotal Voting Rights
2nd Mar 20072:31 pmRNSIssue of Equity
7th Feb 20077:01 amRNSUpdate on Property Disposal
21st Dec 200611:29 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.